CN111936144B - Jak抑制剂 - Google Patents

Jak抑制剂 Download PDF

Info

Publication number
CN111936144B
CN111936144B CN201980020463.5A CN201980020463A CN111936144B CN 111936144 B CN111936144 B CN 111936144B CN 201980020463 A CN201980020463 A CN 201980020463A CN 111936144 B CN111936144 B CN 111936144B
Authority
CN
China
Prior art keywords
methyl
pyrrolo
pyrimidin
amino
azaspiro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201980020463.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN111936144A (zh
Inventor
廖细斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiaxing Baimei Jihua Pharmaceutical Technology Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN111936144A publication Critical patent/CN111936144A/zh
Application granted granted Critical
Publication of CN111936144B publication Critical patent/CN111936144B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201980020463.5A 2018-03-21 2019-03-18 Jak抑制剂 Active CN111936144B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862646167P 2018-03-21 2018-03-21
US62/646,167 2018-03-21
PCT/US2019/022657 WO2019182924A1 (en) 2018-03-21 2019-03-18 Jak inhibitors

Publications (2)

Publication Number Publication Date
CN111936144A CN111936144A (zh) 2020-11-13
CN111936144B true CN111936144B (zh) 2023-12-22

Family

ID=67986579

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980020463.5A Active CN111936144B (zh) 2018-03-21 2019-03-18 Jak抑制剂

Country Status (7)

Country Link
US (1) US11365188B2 (cg-RX-API-DMAC7.html)
EP (1) EP3768272B1 (cg-RX-API-DMAC7.html)
JP (1) JP7462951B2 (cg-RX-API-DMAC7.html)
CN (1) CN111936144B (cg-RX-API-DMAC7.html)
AU (1) AU2019237991B2 (cg-RX-API-DMAC7.html)
CA (1) CA3093706A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019182924A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102218333B1 (ko) 2016-06-07 2021-02-22 자코바이오 파마슈티칼스 컴퍼니 리미티드 Shp2 억제제로서 유용한 신규한 헤테로환형 유도체
SG11201908820VA (en) 2017-03-23 2019-10-30 Jacobio Pharmaceuticals Co Ltd Novel heterocyclic derivatives useful as shp2 inhibitors
CN112839935A (zh) 2018-09-26 2021-05-25 北京加科思新药研发有限公司 可用作shp2抑制剂的新型杂环衍生物
JP2022506682A (ja) * 2018-11-05 2022-01-17 アビスタ ファーマ ソリューションズ,インコーポレーテッド 化合物
CN113498352A (zh) 2019-01-23 2021-10-12 施万生物制药研发Ip有限责任公司 作为jak抑制剂的咪唑并[1,5-a]吡啶、1,2,4-三唑并[4,3-a]吡啶和咪唑并[1,5-a]吡嗪
DK3915989T3 (da) 2019-01-30 2023-09-18 Felicamed Biotechnology Co Ltd Jak inhibitor and preparation method therefor
TW202227452A (zh) * 2020-12-04 2022-07-16 大陸商廣州費米子科技有限責任公司 氮雜並環化合物、其製備方法、抑制酪氨酸激酶的方法、藥物組成物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6075736B2 (ja) 2011-12-21 2017-02-08 ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co.,Ltd. ピロール−6員ヘテロアリール環誘導体、その合成法およびその医薬用途
LT3077395T (lt) 2013-12-05 2018-02-12 Pfizer Inc. Pirolo[2,3-d]pirimidinilo, pirolo[2,3-b]pirazinilo ir pirolo[2,3-d]piridinilo akrilamidai
US9340540B2 (en) 2014-02-28 2016-05-17 Nimbus Lakshmi, Inc. TYK2 inhibitors and uses thereof
WO2016024185A1 (en) * 2014-08-12 2016-02-18 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase
ES2962330T3 (es) 2015-01-20 2024-03-18 Wuxi Fortune Pharmaceutical Co Ltd Inhibidor de jak
WO2018169700A1 (en) 2017-03-14 2018-09-20 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Design, synthesis and evaluation of (R)-3-(7-(methylIJ7H-pyrroloij2,3-d]pyrimidin-4-yl)amino)-5-azaspiroij2.4]heptan-5-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor;Chieyeon Chough等;《MedChemComm》(第undefined期);第477-489页 *

Also Published As

Publication number Publication date
US11365188B2 (en) 2022-06-21
EP3768272B1 (en) 2025-07-30
CA3093706A1 (en) 2019-09-26
WO2019182924A1 (en) 2019-09-26
AU2019237991B2 (en) 2025-01-02
AU2019237991A1 (en) 2020-10-15
JP2021518379A (ja) 2021-08-02
CN111936144A (zh) 2020-11-13
JP7462951B2 (ja) 2024-04-08
US20210053943A1 (en) 2021-02-25
EP3768272A1 (en) 2021-01-27
EP3768272A4 (en) 2021-08-11

Similar Documents

Publication Publication Date Title
KR102429419B1 (ko) Rho-키나아제 억제제로서 티로신 아마이드 유도체
CN110062758B (zh) 作为rho-激酶抑制剂的二环二氢嘧啶-甲酰胺衍生物
KR101792837B1 (ko) 키나아제 억제제로서 사용을 위한 이미다조피라진
CN104918945B (zh) 作为jak抑制剂的三环稠合噻吩衍生物
CN101983199B (zh) 1-杂环基-1,5-二氢-吡唑并[3,4-d]嘧啶-4-酮衍生物及其作为pde9a调节剂的用途
CN104884458B (zh) 作为蛋白质激酶抑制剂的稠合杂环化合物
JP7462951B2 (ja) Jak阻害剤
RS53167B (sr) Derivati 1-heterociklil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona i njihova primena u vidu pde9a modulatora
CN101647802A (zh) 具有PDE-5抑制活性的5,7-二氨基吡唑并[4,3-d]嘧啶及其组合物
JP2020506899A (ja) Magl阻害薬としての1,1,1−トリフルオロ−3−ヒドロキシプロパン−2−イルカルバマート誘導体
CN104837844B (zh) 作为酪蛋白激酶1 d/e抑制剂的吡唑取代的咪唑并哌嗪
SG183551A1 (en) Piperidin-4-yl azetidine derivatives as jak1 inhibitors
CN114805361B (zh) 一类氨基取代的芳香杂环并吡唑类化合物、制备方法和用途
TWI222449B (en) Triazolo-pyridazine derivatives as ligands for GABA receptors
WO2016192630A1 (zh) 一类具有激酶抑制活性的化合物、制备方法和用途
CN116888126B (zh) 一种酪蛋白激酶抑制剂的化合物
CN113429427A (zh) 杂环化合物及其制备方法和药物用途
CN111808077B (zh) 哌嗪酰胺衍生物,其制备方法及其在医药上的用途
CN116693538A (zh) 一种吡唑并嘧啶类衍生物、其制备方法及用途
CN115703783A (zh) 吡咯并嘧啶类衍生物及其制备方法和用途
HK40077297B (en) Aza-quinoline compounds and uses thereof
HK40010452A (en) Bicyclic dihydropyrimidine-carboxamide derivatives as rho-kinase inhibitors
HK1156606A (en) Pyrazolopyrimidines and their use for the treatment of cns disorders

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20251020

Address after: 314000 Zhejiang Province Jiaxing City Jiashan County Minhu Street Qiantang River Road 168 Building 17

Patentee after: Jiaxing Baimei Jihua Pharmaceutical Technology Co.,Ltd.

Country or region after: China

Address before: 101 Sherman Avenue, Edison, NJ, USA

Patentee before: Liao Xibin

Country or region before: U.S.A.